Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

25-Hydroxycholesterol

Home Drugs25-Hydroxycholesterol

Experimental

Small Molecule

25-Hydroxycholesterol

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Technical identifiers

Chemical Formula: C₂₇H₄₆O₂
CAS Number: 2140-46-7
UNII ID: 767JTD2N31

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

25-HYDROXYCHOLESTEROL (25HC), CRYAB AGGREGATION INHIBITOR TO AMELIORIATE VASCULAR STIFFNESS
Applicant: BUCK INST RES AGINGPriority: 2022
US
Preparation containing 25-hydroxycholesterol and preparation method thereof and anti-virus application
Applicant: SUZHOU INST OF SYSTEMS MEDICINEPriority: 2014
CN
Application of 25-hydroxycholesterol in preparation of medicine for treating osteoporosis and osteolysis
Applicant: SUZHOU INST OF SYSTEMS MEDICINEPriority: 2024
CN
Application of 25-hydroxycholesterol in preparation of medicine for inhibiting macrophage scavenger receptor 1
Applicant: THE FIRST AFFILIATED HOSPITAL COLLEGE OF MEDICINE ZHEJIANG UNIVPriority: 2023
CN
Application of 25-hydroxycholesterol in preparation of aquatic organism disease prevention and treatment preparation
Applicant: UNIV SHANDONGPriority: 2020
CN
Hydroxycholesterol immunoassay
Applicant: MULLENIX MICHAEL CPriority: 2010
US
6 publications
Use of oxygenated cholesterol sulfates for treating at least one of insulin resistance, diabetes, and prediabetes
Applicant: MEDICIS PHARMACEUTICAL CORPPriority: 2021
US
Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation
Applicant: REN SHUNLINPriority: 2012
US
3 publications